Gentile Kimberly — SEC insider filings
SEC reporting owner CIK 1704186. 13 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2020-10-09 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 23,500 shares, $1,794,082 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 88.
- Largest priced transaction: sale of 15,781 shares @ $76.42 ($1,205,938) in Biohaven Pharmaceutical Holding Co Ltd., filed 2020-10-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | SVP, Clinical Operations | 6 | — | 3 legs · 23,500 sh · $1,794,082 | 34 |
| Biohaven Ltd. (BHVN) | SVP, Clinical Operations | 7 | — | — | 54 |
Insider filings — Gentile Kimberly
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Biohaven Ltd. (BHVN) | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Biohaven Ltd. (BHVN) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Biohaven Ltd. (BHVN) | Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,956 @ $9.93 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Biohaven Ltd. (BHVN) | Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,956 @ $38.64 · Grant/award (A): 91,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Biohaven Ltd. (BHVN) | Grant/award (A): 96,250 (derivative) @ $0 | EDGAR |
| 2023-11-06 | 4 | Biohaven Ltd. (BHVN) | Grant/award (A): 78,750 (derivative) @ $0 | EDGAR |
| 2022-10-05 | 4 | Biohaven Ltd. (BHVN) | Other (J): 5,826 @ $0 · Other (J): 6,500 @ $0 · Other (J): 3,750 @ $0 · Other (J): 1,875 @ $0 · Option exercise (M): 387 @ $6.37 · Option exercise (M): 12,612 @ $6.37 · +36 more | EDGAR |
| 2022-10-03 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Disposition to issuer (D): 11,653 @ $148.50 · Disposition to issuer (D): 13,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 3,750 (derivative) · Disposition to issuer (D): 775 (derivative) · Disposition to issuer (D): 25,225 (derivative) · +10 more | EDGAR |
| 2022-01-07 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,800 @ $123.86 · Option exercise (M): 3,750 (derivative) @ $0 · Grant/award (A): 26,000 (derivative) @ $0 · Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2021-11-26 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,738 @ $115.55 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,747 @ $83.38 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2020-11-27 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,701 @ $90.14 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2020-10-09 | 4 | Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Option exercise (M): 23,500 @ $9.29 · Sale (S): 5,261 @ $75.62 · Sale (S): 15,781 @ $76.42 · Sale (S): 2,458 @ $77.42 · Sale (S): 23,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1704186 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs